alpha-glucosidase inhibitors

alpha-glucosidase inhibitors

Drugs used to treat Type II (non-insulin-dependent) DIABETES. An example is acarbose (Glucobay).

alpha-glucosidase inhibitors (al´fəglōōkō´sidās´),

n.pl an orally administered agent used in the treatment of type 2 diabetes mellitus. Examples include acarbose, which slows the digestion and absorption of glucose into the bloodstream.
References in periodicals archive ?
And these treatment categories: - Thiazolidinediones - Alpha-glucosidase inhibitors - Meglitinides - Sodium-glucose co-transporter-2 inhibitors (SGLT2) - Other agents (grouped).
Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020
Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update.
The two alpha-glucosidase inhibitors acarbose (Precose) and miglitol (Glyset) delay the digestion of carbohydrates within the gastrointestinal tract, thereby reducing the rise in blood glucose following meals.
According to study authors, the herb seems to work similarly to oral diabetes drugs known as alpha-glucosidase inhibitors, which impede the body's absorption of carbohydrates.
The alpha-glucosidase inhibitors are competitive, reversible inhibitors of alpha-amylase from the pancreas and alpha-glucosidase, which is found in the brush border of the small intestine.
Possible combinations with sulfonylurea drugs, alpha-glucosidase inhibitors and biguanide drugs can be foreseen.
Alpha-glucosidase inhibitors (AL-fa gloo-KOS-ih-dayss in-HIB-it-ers).
Find Your Diabetes Medicines(*) Sulfonylureas Amaryl DiaBeta Diabinese Dymelor Glucotrol Glucotrol XL Glynase PresTab Micronase Orinase Tolinase Biguanides Glucophage Alpha-glucosidase Inhibitors Glyset Precose Thiazolidinediones Rezulin Meglitinides: Prandin Insulins Lispro (Humalog) Regular Premixed Ultralente NPH or Lente
And these treatment categories: -- Thiazolidinediones -- Alpha-glucosidase inhibitors -- Meglitinides -- Sodium-glucose co-transporter-2 inhibitors (SGLT2) -- Other agents (grouped).
Alpha-glucosidase inhibitors delay the digestion of oligosaccharide and disaccharide to monosaccharide by inhibiting [alpha]-glucosidases on the small intestinal brush-border, and reduce the rate of glucose absorption.